Histopathological markers of treatment response and recurrence risk in ovarian cancers and borderline tumors
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pathology and Forensic Medicine
Link
http://link.springer.com/article/10.1007/s00292-017-0375-9/fulltext.html
Reference117 articles.
1. Avril S et al (2012) Histopathologic features of ovarian borderline tumors are not predictive of clinical outcome. Gynecol Oncol 127(3):516–524
2. Sassen S et al (2007) Histopathologic assessment of tumor regression after neoadjuvant chemotherapy in advanced-stage ovarian cancer. Hum Pathol 38(6):926–934
3. Avril-Sassen S et al (2009) Characterisation of microRNA expression in post-natal mouse mammary gland development. BMC Genomics 10:548
4. Raychaudhuri M et al (2012) Intratumoral Heterogeneity of MicroRNA Expression in Breast Cancer. J Mol Diagn 14(4):376–384
5. Malinowsky K et al (2012) Common protein biomarkers assessed by reverse phase protein arrays show considerable intratumoral heterogeneity in breast cancer tissues. PLOS ONE 7(7):e40285
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Integrated biomarker responses: Unveiling insights through serum biochemistry, oxidative stress, genotoxicity and histopathology;Biomarkers in Environmental and Human Health Biomonitoring;2024
2. A multidisciplinary approach remains the best strategy to improve and strengthen the management of ovarian cancer (Review);International Journal of Oncology;2021-06-14
3. Reduced levels of actin gamma 1 predict poor prognosis in ovarian cancer patients;Journal of Obstetrics and Gynaecology Research;2020-06-23
4. Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma: A systematic review and meta-analysis of individual patient data;Gynecologic Oncology;2019-08
5. Laparoendoscopic single-site oophorectomy for a right ovarian borderline serous tumor of stage IC2, a literature review;Obstetrics & Gynecology International Journal;2018-08-16
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3